Staphylococcus aureus extracellular vesicles carry biologically active β-lactamase

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 6, 2013, Pages 2589-2595

  Lee, Jaewook ^a   Lee, Eun Young ^a   Kim, Si Hyun ^a   Kim, Dae Kyum ^a   Park, Kyong Su ^a   Kim, Kwang Pyo ^b   Kim, Yoon Keun ^a   Roh, Tae Young ^a   Gho, Yong Song ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAMASE; BLAZ PROTEIN; CHLORAMPHENICOL; KANAMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; CELL VACUOLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR VESICLE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; SURVIVAL;

AMPICILLIN; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; EXTRACELLULAR SPACE; HUMANS; MICROBIAL SENSITIVITY TESTS; PROTEOLIPIDS; STAPHYLOCOCCUS AUREUS;

EID: 84877854477     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00522-12     Document Type: Article

References (32)

1. Beveridge TJ. 1999. Structures of Gram-negative cell walls and their derived membrane vesicles. J. Bacteriol. 181:4725-4733.
2. Lee EY, Bang JY, Park GW, Choi DS, Kang JS, Kim HJ, Park KS, Lee JO, Kim YK, Kwon KH, Kim KP, Gho YS. 2007. Global proteomic profiling of native outer membrane vesicles derived from Escherichia coli. Proteomics 7:3143-3153.
3. Lee EY, Choi DS, Kim KP, Gho YS. 2008. Proteomics in Gram-negative bacterial outer membrane vesicles. Mass Spectrom. Rev. 27:535-555.
4. Mashburn-Warren LM, Whiteley M. 2006. Special delivery: Vesicle trafficking in prokaryotes. Mol. Microbiol. 61:839-846.
5. Kuehn MJ, Kesty NC. 2005. Bacterial outer membrane vesicles and the host-pathogen interaction. Genes Dev. 19:2645-2655.
6. Mashburn LM, Whiteley M. 2005. Membrane vesicles traffic signals and facilitate group activities in a prokaryote. Nature 437:422-425.
7. Schooling SR, Beveridge TJ. 2006. Membrane vesicles: An overlooked component of the matrices of biofilms. J. Bacteriol. 188:5945-5957.
8. Bomberger JM, Maceachran DP, Coutermarsh BA, Ye S, O'Toole GA, Stanton BA. 2009. Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles. PLoS Pathog. 5:e1000382. doi:10.1371/journal.ppat.1000382.
9. Ciofu O, Beveridge TJ, Kadurugamuwa J, Walther-Rasmussen J, Hoiby N. 2000. Chromosomal beta-lactamase is packaged into membrane vesicles and secreted from Pseudomonas aeruginosa. J. Antimicrob. Chemother. 45:9-13.
10. Wai SN, Lindmark B, Soderblom T, Takade A, Westermark M, Oscarsson J, Jass J, Richter-Dahlfors A, Mizunoe Y, Uhlin BE. 2003. Vesicle-mediated export and assembly of pore-forming oligomers of the enterobacterial ClyA cytotoxin. Cell 115:25-35.
11. Lee EY, Choi DY, Kim DK, Kim JW, Park JO, Kim S, Kim SH, Desiderio DM, Kim YK, Kim KP, Gho YS. 2009. Gram-positive bacteria produce membrane vesicles: Proteomics-based characterization of Staphylococcus aureus-derived membrane vesicles. Proteomics 9:5425-5436.
12. Gurung M, Moon DC, Choi CW, Lee JH, Bae YC, Kim J, Lee YC, Seol SY, Cho DT, Kim SI, Lee JC. 2011. Staphylococcus aureus produces membrane-derived vesicles that induce host cell death. PLoS One 6:e27958. doi:10.1371/journal. pone.0027958.
13. Hong SW, Kim MR, Lee EY, Kim JH, Kim YS, Jeon SG, Yang JM, Lee BJ, Pyun BY, Gho YS, Kim YK. 2011. Extracellular vesicles derived from Staphylococcus aureus induce atopic dermatitis-like skin inflammation. Allergy 66:351-359.
14. Kim MR, Hong SW, Choi EB, Lee WH, Kim YS, Jeon SG, Jang MH, Gho YS, Kim YK. 2012. Staphylococcus aureus-derived extracellular vesicles induce neutrophilic pulmonary inflammation via both Th1 and Th17 cell responses. Allergy 67:1271-1281.
15. Rivera J, Cordero RJ, Nakouzi AS, Frases S, Nicola A, Casadevall A. 2010. Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins. Proc. Natl. Acad. Sci. U. S. A. 107:19002-19007.
16. Volardri RK, Kernodle DS. 1998. Characterization of a chromosomal gene encoding type B β-lactamase in phage group II isolates of Staphylococcus aureus. Antimicrob. Agents Chemother. 42:3163-3168.
17. Kernodle DS, Zygmunt DJ, McGraw PA, Chipley Jr. 1990. Purification of Staphylococcus aureus beta-lactamases by using sequential cationexchange and affinity chromatography. Antimicrob. Agents Chemother. 34:2177-2183.
18. Scherl A, Francois P, Converset V, Bento M, Burgess JA, Sanchez JC, Hochstrasser DF, Schrenzel J, Corthals GL. 2004. Nonredundant mass spectrometry: A strategy to integrate mass spectrometry acquisition and analysis. Proteomics 4:917-927.
19. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
20. Coquet L, Junter GA, Jouenne T. 1998. Resistance of artificial biofilms of Pseudomonas aeruginosa to imipenem and tobramycin. J. Antimicrob. Chemother. 42:755-760.
21. Nesin M, Svec P, Lupski JR, Godson GN, Kreiswirth B, Kornblum J, Projan SJ. 1990. Cloning and nucleotide sequence of a chromosomally encoded tetracycline resistance determinant, tetA(M), from a pathogenic, methicillin-resistant strain of Staphylococcus aureus. Antimicrob. Agents Chemother. 34:2273-2276.
22. Horinouchi S, Weisblum B. 1982. Nucleotide sequence and functional map of pC194, a plasmid that specifies inducible chloramphenicol resistance. J. Bacteriol. 150:815-825.
23. Gray GS, Fitch WM. 1983. Evolution of antibiotic resistance genes: The DNA sequence of a kanamycin resistance gene from Staphylococcus aureus. Mol. Biol. Evol. 1:57-66.
24. Granieri L, Baret JC, Griffiths AD, Merten CA. 2010. High-throughput screening of enzymes by retroviral display using droplet-based microfluidics. Chem. Biol. 17:229-235.
25. Azucena E, Mobashery S. 2001. Aminoglycoside-modifying enzymes: Mechanisms of catalytic processes and inhibition. Drug Resist. Update 4:106-117.
26. Charette SJ, Lambert H, Nadeau PJ, Landry J. 2010. Protein quantification by chemiluminescent Western blotting: Elimination of the antibody factor by dilution series and calibration curve. J. Immunol. Methods 353:148-150.
27. Ricci V, Chiozzi V, Necchi V, Oldani A, Romano M, Solcia E, Ventura U. 2005. Free-soluble and outer membrane vesicle-associated VacA from Helicobacter pylori: Two forms of release, a different activity. Biochem. Biophys. Res. Commun. 337:173-178.
28. Lee HM, Choi EJ, Kim JH, Kim TD, Kim YK, Kang C, Gho YS. 2010. A membranous form of ICAM-1 on exosomes efficiently blocks leukocyte adhesion to activated endothelial cells. Biochem. Biophys. Res. Commun. 397:251-256.
29. Zeelenberg IS, Ostrowski M, Krumeich S, Bobrie A, Jancic C, Boissonnas A, Delcayre A, Le Pecq JB, Combadiere B, Amigorena S, Thery C. 2008. Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses. Cancer Res. 68:1228-1235.
30. Ellis TN, Kuehn MJ. 2010. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol. Mol. Biol. Rev. 74:81-94.
31. Kadurugamuwa JL, Beveridge TJ. 1996. Bacteriolytic effect of membrane vesicles from Pseudomonas aeruginosa on other bacteria including pathogens: Conceptually new antibiotics. J. Bacteriol. 178:2767-2774.
32. Rohde H, Burdelski C, Bartscht K, Hussain M, Buck F, Horstkotte MA, Knobloch JK, Heilmann C, Herrmann M, Mack D. 2005. Induction of Staphylococcus epidermidis biofilm formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host proteases. Mol. Microbiol. 55:1883-1895.